Roche Seeks ‘Targeted Acquisitions,’ Not Abbott-Sized Deal
By Naomi Kresge - Oct 21, 2011 5:51 AM CT
Roche Holding AG (ROG) will continue to pursue a strategy of “targeted acquisitions” to complement its existing portfolio and isn’t seeking a mega-merger, Chief Executive Officer Severin Schwan said today.
“We’ve focused on smaller, bolt-on acquisitions,” Schwan said in an interview in Frankfurt after being asked whether an acquisition of a portion of Abbott Laboratories (ABT)’ business is attractive. “That’s how I see us continuing in our M&A strategy. We are not interested in mega-mergers. We are interested in very targeted acquisitions which complement our technologies and portfolios.”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.